ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 92 filers reported holding ARATANA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $8,569,000 | -14.2% | 1,629 | 0.0% | 0.00% | – |
| Q3 2017 | $9,986,000 | -20.8% | 1,629 | -6.6% | 0.00% | – |
| Q2 2017 | $12,616,000 | +36.4% | 1,745 | 0.0% | 0.00% | – |
| Q1 2017 | $9,249,000 | +61560.0% | 1,745 | -16.1% | 0.00% | – |
| Q4 2016 | $15,000 | -96.1% | 2,079 | -96.6% | 0.00% | – |
| Q2 2016 | $387,000 | -34.3% | 61,267 | -42.6% | 0.00% | -100.0% |
| Q1 2016 | $589,000 | -28.2% | 106,685 | -27.4% | 0.00% | 0.0% |
| Q4 2015 | $820,000 | +2.2% | 146,936 | +55.0% | 0.00% | 0.0% |
| Q3 2015 | $802,000 | +189.5% | 94,808 | +418.1% | 0.00% | – |
| Q2 2015 | $277,000 | +23.7% | 18,300 | +30.7% | 0.00% | – |
| Q1 2015 | $224,000 | -7.1% | 14,000 | +3.7% | 0.00% | – |
| Q4 2014 | $241,000 | +77.2% | 13,500 | 0.0% | 0.00% | – |
| Q3 2014 | $136,000 | – | 13,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engaged Capital LLC | 3,487,149 | $21,376,000 | 3.96% |
| Broadfin Capital, LLC | 4,083,135 | $25,030,000 | 3.29% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 1.30% |
| GENERAL AMERICAN INVESTORS CO INC | 1,599,365 | $9,804,000 | 1.03% |
| Grandeur Peak Global Advisors, LLC | 821,038 | $5,033,000 | 0.65% |
| CADENCE CAPITAL MANAGEMENT LLC | 307,294 | $1,884,000 | 0.19% |
| Redmond Asset Management, LLC | 60,176 | $369,000 | 0.18% |
| Alambic Investment Management, L.P. | 65,000 | $398,000 | 0.17% |
| MENTA CAPITAL LLC | 39,562 | $243,000 | 0.09% |
| Campbell & CO Investment Adviser LLC | 12,990 | $88,000 | 0.09% |